Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Huntsman Cancer Institute/University of Utah · Salt Lake City, Utah
Answer a few short questions to share with the research team.